
HALAVEN® (eribulin mesylate) Injection: Treatment for …
Learn about HALAVEN® (eribulin mesylate), an injectable treatment for patients with third-line Metastatic Breast Cancer (mBC). See the full Indication and Important Safety Information for HALAVEN®.
What is HALAVEN® (eribulin mesylate) Injection | FDA-Approved …
Learn more about FDA-approved HALAVEN®, a chemotherapy treatment for metastatic breast cancer. Please see the full Indication and Important Safety Information for HALAVEN®.
Eribulin - Wikipedia
Eribulin, sold under the brand name Halaven among others, is an anti-cancer medication used to treat breast cancer and liposarcoma. [ 4 ] [ 5 ] The most common side effects include fatigue, nausea, hair loss (alopecia), constipation, certain nerve damage causing weakness or numbness in the hands and feet (peripheral neuropathy), abdominal pain ...
艾瑞布林(Halaven,Eribulin)FDA官方说明书 - 知乎
halaven是适用于转移乳癌的治疗,为转移疾病的治疗患者既往至少曾接受两种化疗方案。既往治疗应已包括一种蒽环类和一种紫杉烷类在或者辅助或转移情况。 2 剂量和给药方法. 2.1 推荐剂量. halaven的推荐剂量是1.4 mg/平方m静脉给药历时2至5分钟21天疗程的第1和8天。
中国乳腺癌新药!卫材原研药Halaven (海乐卫,艾立布林)正式上 …
2020年01月13日讯 /生物谷BIOON/ --日本药企卫材(Eisai)近日宣布,该公司已在中国推出其自主研发的抗癌药Halaven(中文商品名:海乐卫,通用名:甲磺酸艾立布林,eribulin mesylate)。 在中国,被诊断为乳腺癌的女性人数近年来有所增加,乳腺癌已成为中国女性诊断高发癌症之一,2018年新增乳腺癌病例37万例,死亡10万例。 艾立. 2020年01月13日讯 / 生物谷 BIOON/ --日本药企卫材(Eisai)近日宣布,该公司已在中国推出其自主研发的抗癌药Halaven(中文商品 …
Metastatic Breast Cancer (mBC) Treatment - HALAVEN
HCPs can learn about HALAVEN® (eribulin mesylate) Injection, a treatment for patients with third-line Metastatic Breast Cancer (mBC). View Important Safety Information and Prescribing Information.
Halaven Uses, Dosage, Side Effects & Warnings - Drugs.com
2024年9月26日 · Halaven is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Halaven is used to treat breast cancer that has spread to other parts of the body (metastatic). Halaven is also used to treat liposarcoma, a rare type of cancer that develops in fatty tissue anywhere in the body.
Halaven - European Medicines Agency (EMA)
Halaven is a cancer medicine that contains the active substance eribulin. It is available as a solution for injection. What is Halaven used for? Halaven is used to treat locally advanced or metastatic breast cancer which has continued to spread after at least one previous treatment for advanced cancer.
重磅!卫材新型抗癌药Halaven中国乳腺癌III期临床获得成功,上 …
日本药企卫材(Eisai)近日宣布,在中国开展的有关新型抗癌药Halaven(eribulin mesylate,甲磺酸艾瑞布林)的一项乳腺癌III期临床研究(Study 304)获得成功。该研究在中国的局部复发或转移性乳腺癌女性患者中开展,数据显示,与抗肿瘤药长春瑞滨(vinorelbine)治疗 ...
HALAVEN- eribulin mesylate injection - DailyMed
2024年11月18日 · HALAVEN is a prescription medicine used to treat people with: Breast cancer ° that has spread to other parts of the body, and ° who have already received certain types of anticancer medicines after the cancer has spread